EFFICACY OF INCOBOTULINUMTOXINA FOR TREATMENT OF GLABELLAR FROWN LINES IN MALE SUBJECTS: POST HOC ANALYSES FROM RANDOMIZED, DOUBLE-BLIND PIVOTAL STUDIES

被引：0
|
作者：
Jones, Derek H. [1 ]
Kerscher, Martina [2 ]
Geister, Thorin [3 ]
Hast, Michael A. [4 ]
Weissenberger, Petra [3 ]
机构：
[1] Skin & Laser Phys Beverly Hills, Beverly Hills, CA USA
[2] Univ Hamburg, Div Cosmet Sci, Hamburg, Germany
[3] Merz Pharmaceut GmbH, Frankfurt, Germany
[4] Merz North Amer, Raleigh, NC USA
来源：
TOXICON | 2018年 / 156卷
关键词：
Aesthetic use; Efficacy; IncobotulinumtoxinA; Male cohort; Post hoc analysis;
D O I：
10.1016/j.toxicon.2018.11.124
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
114
引用
收藏
页码：S52 / S52
页数：1
相关论文
共 50 条
  • [1] Efficacy of incobotulinumtoxinA for the treatment of glabellar frown lines in male subjects: Post hoc analyses from randomized double-blind pivotal studies
    Jones, Derek
    Kerscher, Martina
    Geister, Thorin
    Hast, Michael
    Weissenberger, Petra
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB124 - AB124
  • [2] Efficacy of IncobotulinumtoxinA for the Treatment of Glabellar Frown Lines in Male Subjects: Post-Hoc Analyses From Randomized, Double-Blind Pivotal Studies
    Jones, Derek H.
    Kerscher, Martina
    Geister, Thorin
    Hast, Michael A.
    Weissenberger, Petra
    DERMATOLOGIC SURGERY, 2017, 43 : S235 - S241
  • [3] Safety and efficacy of escalating doses of incobotulinumtoxina for extended treatment of glabellar frown lines: A randomized double-blind study
    Maas, Corey
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB250 - AB250
  • [4] ESCALATING DOSES OF INCOBOTULINUMTOXINA FOR EXTENDED TREATMENT OF GLABELLAR FROWN LINES: SAFETY AND EFFICACY RESULTS FROM A RANDOMIZED, DOUBLE-BLIND STUDY
    Maas, Corey
    TOXICON, 2018, 156 : S70 - S71
  • [5] A Randomized, Double-Blind Trial to Investigate the Equivalence of IncobotulinumtoxinA and OnabotulinumtoxinA for Glabellar Frown Lines
    Kane, Michael A. C.
    Gold, Michael H.
    Coleman, William P., III
    Jones, Derek H.
    Tanghetti, Emil A.
    Alster, Tina S.
    Rohrer, Tom E.
    Burgess, Cheryl M.
    Shamban, Ava T.
    Finn, Eleanor
    DERMATOLOGIC SURGERY, 2015, 41 (11) : 1310 - 1319
  • [6] Onset and duration of effect of incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA in the treatment of glabellar frown lines: a randomized, double-blind study
    Rappl, Thomas
    Parvizi, Daryousch
    Friedl, Herwig
    Wiedner, Maria
    May, Simone
    Kranzelbinder, Bettina
    Wurzer, Paul
    Hellbom, Bengt
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2013, 6 : 211 - 219
  • [7] IncobotulinumtoxinA for Glabellar Frown Lines in Chinese Subjects: A Randomized, Double-blind, Active-Controlled Phase-3 Study
    Wu, Yan
    Roll, Susanna
    Klein, Gudrun
    Geister, Thorin L.
    Makara, Michael A.
    Li, Bi
    PLASTIC AND RECONSTRUCTIVE SURGERY-GLOBAL OPEN, 2023, 11 (05) : e4956
  • [8] Efficacy of IncobotulinumtoxinA for Treatment of Glabellar Frown Lines: A Post Hoc Pooled Analysis of 2 Randomized, Placebo-Controlled, Phase 3 Trials
    Jones, Derek
    Carruthers, Jean
    Narins, Rhoda S.
    Coleman, William P., III
    Harrington, Laura
    Brandt, Fredric S.
    Cohen, Joel L.
    DERMATOLOGIC SURGERY, 2014, 40 (07) : 776 - 785
  • [9] Efficacy of IncobotulinumtoxinA for treatment of glabellar frown lines: A post hoc pooled analysis of 2 randomized, placebo-controlled phase III trials
    Jones, Derek
    Brandt, Fredric
    Carruthers, Jean
    Cohen, Joel
    Narins, Rhoda
    Coleman, William
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) : AB15 - AB15
  • [10] A Randomized, Placebo-Controlled, Double-Blind Phase III Trial Investigating the Efficacy and Safety of IncobotulinumtoxinA in the Treatment of Glabellar Frown Lines Using a Stringent Composite Endpoint
    Hanke, C. William
    Narins, Rhoda S.
    Brandt, Fredric
    Cohen, Joel L.
    Donofrio, Lisa M.
    Downie, Jeanine
    Heinz, Moritz
    Harrington, Laura
    McDaniel, David H.
    Nestor, Mark
    Schlessinger, Joel
    Schloebe, Andrea
    Taub, Amy
    Weiss, Robert A.
    DERMATOLOGIC SURGERY, 2013, 39 (06) : 891 - 899
12345